Average Insider

Where insiders trade, we follow

$LQDA
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
Healthcare
Sector
Biotechnology
Industry
Roger A. Jeffs
CEO
170
Employees
$68.63
Current Price
$3.40B
Market Cap
52W Low$21.15
Current$68.6365.5% above low, 34.5% below high
52W High$93.61

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00--All Sells
Sells11$18,566.32274
2 weeksBuys00--All Sells
Sells11$18,566.32274
1 monthBuys00--All Sells
Sells47$15,165,431.44208,621
2 monthsBuys00--All Sells
Sells1135$47,718,019.26605,301
3 monthsBuys00--All Sells
Sells1164$120,269,778.041,639,484
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Jun 8, 2026
Bloch Stephen M
Director
Sale106,310$64.49$6,856,367.77View Details
Jun 8, 2026
Bloch Stephen M
Director
Sale39,187$65.38$2,562,030.39View Details
Jun 8, 2026
Bloch Stephen M
Director
Sale2,804$66.19$185,591.15View Details
Jun 9, 2026
Bloch Stephen M
Director
Sale64,500$64.27$4,145,531.10View Details
Jun 5, 2026
Bloch Stephen M
Director
Sale2,064$64.14$132,383.72View Details
108 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Version: v26.7.3